Add to ORKGTumor hypoxia is well known to reduce cancer treatment efficacy. Fluor-19 MRI oximetry can be used to map oxygen concentrations in hypoxic tissue. In this study a reproducible phantom which mimics oxygen consuming tissue is used for quantitative dynamic fluor-19 MRI oximetry. The phantom consists of a hemodialysis filter of which the outer compartment is filled with a gelatin matrix containing viable yeast cells and perfluorocarbon vesicles which simulate the absorption of perfluorocarbons from intravenous emulsions in tissue. The phantom can be used for hypoxia simulations and for validating computational biophysical models of hypoxia, as measured with fluor-19 MRI oximetry.1 page(s
Item does not contain fulltextTumour hypoxia can be assessed by positron emission tomography (PET) u...
18F-fluoromisonidazole (18F-FMISO) is the most widely used PET agent for imaging hypoxia, a conditio...
PURPOSE: Acute hypoxia (transient cycles of hypoxia-reoxygenation) is known to occur in solid tumors...
Tumor hypoxia is well known to reduce cancer treatment efficacy. Fluor-19 MRI oximetry can be used t...
This study presents a reproducible phantom which mimics oxygen-consuming tissue and can be used for ...
Tumor hypoxia is well known to reduce cancer treatment efficacy. Fluor-19 MRI oximetry can be used t...
Objective: This study presents a reproducible phantom which mimics oxygen-consuming tissue and can b...
The impact of the partitioning of oxygenation markers (perfluorocarbons) between blood and tissue in...
In (FMRI)-F-19 oximetry, a method used to image tumour hypoxia, perfluorocarbons serve as oxygenatio...
In ¹⁹F MRI oximetry, a method used to image tumour hypoxia, perfluorocarbons serve as oxygenation ma...
The aim of this study was to develop an MRI fluorocarbon oximetry technique using snapshot inversion...
Tumour hypoxia can be assessed by positron emission tomography (PET) using radiotracers like [(18)F]...
Quantifying oxygenation in viable tumor remains a major obstacle toward a better understanding of th...
Positron emission tomography (PET) using 18F-fluoromisonidazole (FMISO) is a promising technique for...
In cancer therapy, tumour hypoxia is an important predictor of disease progression, treatment outcom...
Item does not contain fulltextTumour hypoxia can be assessed by positron emission tomography (PET) u...
18F-fluoromisonidazole (18F-FMISO) is the most widely used PET agent for imaging hypoxia, a conditio...
PURPOSE: Acute hypoxia (transient cycles of hypoxia-reoxygenation) is known to occur in solid tumors...
Tumor hypoxia is well known to reduce cancer treatment efficacy. Fluor-19 MRI oximetry can be used t...
This study presents a reproducible phantom which mimics oxygen-consuming tissue and can be used for ...
Tumor hypoxia is well known to reduce cancer treatment efficacy. Fluor-19 MRI oximetry can be used t...
Objective: This study presents a reproducible phantom which mimics oxygen-consuming tissue and can b...
The impact of the partitioning of oxygenation markers (perfluorocarbons) between blood and tissue in...
In (FMRI)-F-19 oximetry, a method used to image tumour hypoxia, perfluorocarbons serve as oxygenatio...
In ¹⁹F MRI oximetry, a method used to image tumour hypoxia, perfluorocarbons serve as oxygenation ma...
The aim of this study was to develop an MRI fluorocarbon oximetry technique using snapshot inversion...
Tumour hypoxia can be assessed by positron emission tomography (PET) using radiotracers like [(18)F]...
Quantifying oxygenation in viable tumor remains a major obstacle toward a better understanding of th...
Positron emission tomography (PET) using 18F-fluoromisonidazole (FMISO) is a promising technique for...
In cancer therapy, tumour hypoxia is an important predictor of disease progression, treatment outcom...
Item does not contain fulltextTumour hypoxia can be assessed by positron emission tomography (PET) u...
18F-fluoromisonidazole (18F-FMISO) is the most widely used PET agent for imaging hypoxia, a conditio...
PURPOSE: Acute hypoxia (transient cycles of hypoxia-reoxygenation) is known to occur in solid tumors...